Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119043 | GEO | 2019/08/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (CNV)

Project description:Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcoma

2019-08-23 | GSE119042 | GEO

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (expression)

Project description:Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcoma

2019-08-23 | GSE119041 | GEO

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas

Project description:Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas

| PRJNA487811 | ENA

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (CNV)

Project description:Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (CNV)

| PRJNA487813 | ENA

Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (expression)

Project description:Thermo Fisher Scientific OncoScan expression array data for undifferentiated uterine sarcomas (expression)

| PRJNA487812 | ENA

Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.

Project description:Undifferentiated uterine sarcoma is a diagnosis of exclusion with limited molecular genetic data available. Recent recognition of high-grade endometrial stromal sarcomas with diverse genotypes suggests that some tumors classified as undifferentiated uterine sarcomas may represent misdiagnosed high-grade endometrial stromal sarcomas. Archival material from 10 tumors diagnosed as undifferentiated uterine sarcomas in 2009 to 2017 were collected. BCOR immunohistochemistry and fluorescence in situ hybridization (FISH) using break-apart probes flanking BCOR, ZC3H7B, CCNB3, YWHAE, NUTM2, JAZF1, and BCORL1 were performed. Tumors lacking or harboring gene rearrangement with no known fusion partner by FISH were subjected to targeted RNA sequencing. Morphology was correlated with FISH and sequencing results. BCOR expression was moderate to strong in ≥50% of cells in 8 tumors, while weak in <5% cells and negative in 2. FISH detected mutually exclusive ZC3H7B-BCOR and YWHAE-NUTM2 fusions in 3 uniform undifferentiated uterine sarcomas; 2 pleomorphic tumors harbored YWHAE rearrangement with no known partner. Targeted RNA sequencing of 5 FISH-negative uniform undifferentiated uterine sarcomas detected BRD8-PHF1 and YWHAE-NUTM2B fusions and BCOR internal tandem duplication in 4 of them. Tumors with YWHAE-NUTM2 fusions and BCOR genetic abnormalities showed morphology characteristic of high-grade endometrial stromal sarcomas. No fusions were detected by sequencing in the tumor with YWHAE rearrangement only by FISH. Most tumors classified as undifferentiated uterine sarcomas represent misdiagnosed high-grade endometrial stromal sarcomas. BCOR expression in ≥50% of cells may help triage tumors for molecular confirmation of high-grade endometrial stromal sarcoma-related genetic abnormalities. Novel YWHAE rearrangements may define a subset of true undifferentiated pleomorphic sarcomas.

| S-EPMC6764763 | biostudies-literature

Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.

Project description:Endometrial stromal tumors include translocation-associated low- and high-grade endometrial stromal sarcomas (ESS) and highly malignant undifferentiated uterine sarcomas (UUS). UUS is considered a poorly defined group of aggressive tumors and is often seen as a diagnosis of exclusion after ESS and leiomyosarcoma (LMS) have been ruled out. We performed a comprehensive analysis of gene expression, copy number variation, point mutations, and immune cell infiltrates in the largest series to date of all major types of uterine sarcomas to shed light on the biology of UUS and to identify potential novel therapeutic targets. We show that UUS tumors have a distinct molecular profile from LMS and ESS. Gene expression and immunohistochemical analyses revealed the presence of high numbers of tumor-associated macrophages (TAMs) in UUS, which makes UUS patients suitable candidates for therapies targeting TAMs. Our results show a high genomic instability of UUS and downregulation of several TP53-mediated tumor suppressor genes, such as NDN, CDH11, and NDRG4. Moreover, we demonstrate that UUS carry somatic mutations in several oncogenes and tumor suppressor genes implicated in RAS/PI3K/AKT/mTOR, ERBB3, and Hedgehog signaling.

| S-EPMC5453711 | biostudies-literature

Expression data from Synovial Sarcomas

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-08-09 | E-GEOD-40025 | biostudies-arrayexpress

Expression data (micro-array and RNA-seq, frozen tumors and FFPE blocks) from various sarcomas

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-03-03 | E-GEOD-71121 | biostudies-arrayexpress

Expression data (micro-array and RNA-seq, frozen tumors and FFPE blocks) from various sarcomas

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-03-03 | GSE71121 | GEO